| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.89e-09 | 21 | 118 | 6 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.97e-09 | 11 | 118 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.27e-08 | 14 | 118 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.48e-06 | 37 | 118 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.48e-06 | 37 | 118 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.84e-06 | 38 | 118 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.84e-06 | 38 | 118 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | RAD51 ERVK-6 ERVK-7 ERVK-10 DMC1 LIG1 LIG3 ERVK-8 ASCC3 ERVK-11 | 3.58e-06 | 262 | 118 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.33e-06 | 79 | 118 | 6 | GO:0004521 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 7.47e-06 | 46 | 118 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.64e-05 | 136 | 118 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.64e-05 | 136 | 118 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | DNA strand exchange activity | 3.46e-05 | 2 | 118 | 2 | GO:0000150 | |
| GeneOntologyMolecularFunction | nuclease activity | 6.97e-05 | 231 | 118 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | DNA ligase (ATP) activity | 1.03e-04 | 3 | 118 | 2 | GO:0003910 | |
| GeneOntologyMolecularFunction | DNA ligase activity | 1.03e-04 | 3 | 118 | 2 | GO:0003909 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 MXRA5 NUP98 LAMB1 ERVK-7 ERVK-10 SHANK2 AHNAK TLN1 ERVK-8 ERVK-18 LTBP1 MUC2 EPB41L1 NUP153 | 2.44e-04 | 891 | 118 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | dATP binding | 3.42e-04 | 5 | 118 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RAD51 ERVK-6 EXOSC10 ERVK-7 ERVK-10 DMC1 LIG1 LIG3 ERVK-8 ASCC3 ERVK-11 SMG6 | 4.39e-04 | 645 | 118 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 5.11e-04 | 6 | 118 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | ligase activity, forming phosphoric ester bonds | 7.13e-04 | 7 | 118 | 2 | GO:0016886 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 7.13e-04 | 7 | 118 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 1.21e-03 | 9 | 118 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 1.95e-03 | 42 | 118 | 3 | GO:0140693 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 2.10e-03 | 152 | 118 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 EXOSC10 REXO4 ERVK-7 ERVK-10 CHKA NT5DC1 SBF1 ERVK-8 ERVK-11 CNP SMG6 | 2.96e-03 | 807 | 118 | 12 | GO:0016788 |
| GeneOntologyBiologicalProcess | DNA integration | 6.40e-09 | 13 | 116 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | ERVK-6 EXOSC10 ERVK-7 ERVK-10 GRHL2 MEN1 LIG1 LIG3 ERVK-8 ERVK-11 SMG6 | 4.25e-08 | 218 | 116 | 11 | GO:0071897 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 4.33e-07 | 83 | 116 | 7 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 7.28e-06 | 48 | 116 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 7.56e-06 | 178 | 116 | 8 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA repair | RAD51 ERVK-6 EXOSC10 REXO4 RNF113A ERVK-7 ERVK-10 MEN1 DMC1 LIG1 LIG3 ERVK-8 ASCC3 ERVK-11 | 1.68e-05 | 648 | 116 | 14 | GO:0006281 |
| GeneOntologyBiologicalProcess | snoRNA splicing | 3.14e-05 | 2 | 116 | 2 | GO:0034247 | |
| GeneOntologyBiologicalProcess | sno(s)RNA processing | 6.03e-05 | 14 | 116 | 3 | GO:0043144 | |
| GeneOntologyBiologicalProcess | DNA ligation | 9.20e-05 | 16 | 116 | 3 | GO:0006266 | |
| GeneOntologyBiologicalProcess | sno(s)RNA metabolic process | 1.57e-04 | 19 | 116 | 3 | GO:0016074 | |
| GeneOntologyBiologicalProcess | lagging strand elongation | 1.87e-04 | 4 | 116 | 2 | GO:0006273 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 1.87e-04 | 4 | 116 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | DNA recombination | 2.37e-04 | 368 | 116 | 9 | GO:0006310 | |
| GeneOntologyBiologicalProcess | negative regulation of protein refolding | 3.10e-04 | 5 | 116 | 2 | GO:0061084 | |
| GeneOntologyBiologicalProcess | DNA repair complex assembly | 3.10e-04 | 5 | 116 | 2 | GO:0090735 | |
| GeneOntologyBiologicalProcess | DNA recombinase assembly | 3.10e-04 | 5 | 116 | 2 | GO:0000730 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 1.84e-04 | 51 | 116 | 4 | GO:0071005 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 2.30e-04 | 54 | 116 | 4 | GO:0071011 | |
| Domain | RECA_3 | 3.56e-05 | 2 | 112 | 2 | PS50163 | |
| Domain | DNA_ligase_ATP-dep_C | 1.07e-04 | 3 | 112 | 2 | IPR012309 | |
| Domain | DNA_ligase_ATP-dep_N | 1.07e-04 | 3 | 112 | 2 | IPR012308 | |
| Domain | DNA_ligase_ATP-dep_cent | 1.07e-04 | 3 | 112 | 2 | IPR012310 | |
| Domain | DNA_LIGASE_A2 | 1.07e-04 | 3 | 112 | 2 | PS00333 | |
| Domain | RecA_monomer-monomer_interface | 1.07e-04 | 3 | 112 | 2 | IPR020587 | |
| Domain | DNA_LIGASE_A3 | 1.07e-04 | 3 | 112 | 2 | PS50160 | |
| Domain | DNA_ligase_ATP-dep | 1.07e-04 | 3 | 112 | 2 | IPR000977 | |
| Domain | DNA_ligase_ATP-dep_CS | 1.07e-04 | 3 | 112 | 2 | IPR016059 | |
| Domain | DNA_ligase_A_M | 1.07e-04 | 3 | 112 | 2 | PF01068 | |
| Domain | - | 1.07e-04 | 3 | 112 | 2 | 1.10.3260.10 | |
| Domain | DNA_LIGASE_A1 | 1.07e-04 | 3 | 112 | 2 | PS00697 | |
| Domain | DNA_ligase_A_C | 1.07e-04 | 3 | 112 | 2 | PF04679 | |
| Domain | DNA_ligase_A_N | 1.07e-04 | 3 | 112 | 2 | PF04675 | |
| Domain | DNA_repair_Rad51/TF_NusA_a-hlx | 2.12e-04 | 4 | 112 | 2 | IPR010995 | |
| Domain | PDZ | 2.68e-04 | 148 | 112 | 6 | SM00228 | |
| Domain | - | 2.89e-04 | 150 | 112 | 6 | 2.30.42.10 | |
| Domain | PDZ | 2.99e-04 | 151 | 112 | 6 | PS50106 | |
| Domain | PDZ | 3.10e-04 | 152 | 112 | 6 | IPR001478 | |
| Domain | Rad51_DMC1_RadA | 5.26e-04 | 6 | 112 | 2 | IPR033925 | |
| Domain | DNA_recomb/repair_RecA-like | 5.26e-04 | 6 | 112 | 2 | IPR016467 | |
| Domain | HHH | 7.34e-04 | 7 | 112 | 2 | PF00633 | |
| Domain | DNA_recomb/repair_Rad51_C | 7.34e-04 | 7 | 112 | 2 | IPR013632 | |
| Domain | RecA_ATP-bd | 7.34e-04 | 7 | 112 | 2 | IPR020588 | |
| Domain | RECA_2 | 7.34e-04 | 7 | 112 | 2 | PS50162 | |
| Domain | HhH_motif | 7.34e-04 | 7 | 112 | 2 | IPR000445 | |
| Domain | Rad51 | 7.34e-04 | 7 | 112 | 2 | PF08423 | |
| Domain | RNaseH-like_dom | 7.85e-04 | 69 | 112 | 4 | IPR012337 | |
| Domain | STI1 | 1.55e-03 | 10 | 112 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 1.55e-03 | 10 | 112 | 2 | IPR006636 | |
| Domain | PDZ | 1.60e-03 | 141 | 112 | 5 | PF00595 | |
| Domain | uDENN | 3.09e-03 | 14 | 112 | 2 | SM00800 | |
| Domain | uDENN | 3.56e-03 | 15 | 112 | 2 | PF03456 | |
| Domain | DENN | 4.05e-03 | 16 | 112 | 2 | SM00799 | |
| Domain | DENN | 4.05e-03 | 16 | 112 | 2 | PF02141 | |
| Domain | dDENN | 4.05e-03 | 16 | 112 | 2 | PF03455 | |
| Domain | UDENN | 4.05e-03 | 16 | 112 | 2 | PS50946 | |
| Domain | DDENN | 4.05e-03 | 16 | 112 | 2 | PS50947 | |
| Domain | dDENN | 4.05e-03 | 16 | 112 | 2 | SM00801 | |
| Domain | dDENN_dom | 4.05e-03 | 16 | 112 | 2 | IPR005112 | |
| Domain | uDENN_dom | 4.05e-03 | 16 | 112 | 2 | IPR005113 | |
| Domain | DENN | 4.05e-03 | 16 | 112 | 2 | PS50211 | |
| Domain | DENN_dom | 4.05e-03 | 16 | 112 | 2 | IPR001194 | |
| Domain | CTCK_1 | 5.12e-03 | 18 | 112 | 2 | PS01185 | |
| Domain | Ig_I-set | 5.77e-03 | 190 | 112 | 5 | IPR013098 | |
| Domain | I-set | 5.77e-03 | 190 | 112 | 5 | PF07679 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | EXOSC10 MYH10 REXO4 TCF20 MECP2 ST13 RTF1 PCF11 LIG3 GTF2E2 SF3B1 DENND5A NUP153 | 1.88e-11 | 283 | 119 | 13 | 30585729 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | STAM2 EXOSC10 MYH10 TBC1D5 RNF113A NACA NUP98 PRPF8 LIG3 GTF2E2 GORASP2 SF3B1 AHNAK TLN1 NUP153 AHNAK2 | 1.31e-07 | 934 | 119 | 16 | 33916271 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.56e-07 | 4 | 119 | 3 | 10469592 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.35e-07 | 123 | 119 | 7 | 26912792 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.89e-07 | 5 | 119 | 3 | 12629516 | |
| Pubmed | EXOSC10 MYH10 REXO4 TCF20 NUP98 PRPF8 SF3B1 SBF1 AHNAK TLN1 RPF2 ASCC3 NUP153 | 4.05e-07 | 653 | 119 | 13 | 22586326 | |
| Pubmed | MYH10 PHACTR2 MYLK NUP98 FNBP1L DCC PRPF8 MECP2 MEN1 PCF11 LMOD3 ACSM3 SF3B1 SHANK2 AHNAK RPF2 CFAP74 ULK1 DYNC1I1 | 4.59e-07 | 1442 | 119 | 19 | 35575683 | |
| Pubmed | REXO4 NACA GPATCH8 ZHX2 MECP2 MEN1 PCF11 GTF2E2 GORASP2 SHANK2 SBF1 TLN1 RPF2 OS9 KDM1B ASCC3 CNP EPB41L1 SMG6 | 8.04e-07 | 1497 | 119 | 19 | 31527615 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 9.00e-07 | 94 | 119 | 6 | 21542922 | |
| Pubmed | MAGI1 MYH10 TCF20 NUP98 LAMB1 PLEKHA6 ST13 SF3B1 OS9 SLC4A4 NUP153 | 9.63e-07 | 486 | 119 | 11 | 20936779 | |
| Pubmed | MYH10 DOCK8 SH3KBP1 PLEKHA6 ECI1 MECP2 ST13 CADM2 GTF2E2 SF3B1 SHANK2 SBF1 TLN1 SLC4A4 ST13P5 CNP EPB41L1 DYNC1I1 | 1.84e-06 | 1431 | 119 | 18 | 37142655 | |
| Pubmed | Disruption of MeCP2-TCF20 complex underlies distinct neurodevelopmental disorders. | 2.16e-06 | 8 | 119 | 3 | 35074918 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | TBC1D5 FNBP1L ZHX2 LIG3 GTF2E2 SF3B1 SALL1 AHNAK TLN1 AHNAK2 | 3.20e-06 | 444 | 119 | 10 | 34795231 |
| Pubmed | 3.27e-06 | 259 | 119 | 8 | 31162944 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EXOSC10 MYH10 REXO4 TCF20 NACA PRPF8 NT5DC1 LIG3 SF3B1 SBF1 AHNAK TLN1 SHCBP1 RPF2 ASCC3 CNP AHNAK2 | 3.72e-06 | 1353 | 119 | 17 | 29467282 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | EXOSC10 MYH10 REXO4 TCF20 GPATCH8 PRPF8 MECP2 PCF11 LIG3 SF3B1 SBF1 RPF2 PCDH15 KDM1B SLC25A19 | 4.55e-06 | 1082 | 119 | 15 | 38697112 |
| Pubmed | PHACTR2 DOCK8 DCC PCF11 CTCFL SHANK2 TRAPPC12 SLIT1 UGT2B7 HEPHL1 NRG3 DYNC1I1 NUP153 | 4.60e-06 | 814 | 119 | 13 | 23251661 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EXOSC10 REXO4 TCF20 NUP98 PRPF8 MECP2 PCF11 LIG3 GTF2E2 SF3B1 SALL1 AHNAK DLX1 NUP153 | 5.10e-06 | 954 | 119 | 14 | 36373674 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 7.08e-06 | 486 | 119 | 10 | 30940648 | |
| Pubmed | STAM2 TBC1D5 LAMB1 TNIP1 GPATCH8 ZHX2 TDRD7 GORASP2 SGMS1 SLIT1 LTBP1 | 8.17e-06 | 608 | 119 | 11 | 16713569 | |
| Pubmed | 9.75e-06 | 215 | 119 | 7 | 35973513 | ||
| Pubmed | Congenital mirror movements: mutational analysis of RAD51 and DCC in 26 cases. | 1.16e-05 | 2 | 119 | 2 | 24808016 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 36625284 | ||
| Pubmed | Mechanisms of distinctive mismatch tolerance between Rad51 and Dmc1 in homologous recombination. | 1.16e-05 | 2 | 119 | 2 | 34871438 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9001252 | ||
| Pubmed | A comparative analysis of Dmc1 and Rad51 nucleoprotein filaments. | 1.16e-05 | 2 | 119 | 2 | 18535008 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19004837 | ||
| Pubmed | Positive and negative regulators of RAD51/DMC1 in homologous recombination and DNA replication. | 1.16e-05 | 2 | 119 | 2 | 38142595 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15007166 | ||
| Pubmed | Interaction between Arabidopsis Brca2 and its partners Rad51, Dmc1, and Dss1. | 1.16e-05 | 2 | 119 | 2 | 16415210 | |
| Pubmed | ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. | 1.16e-05 | 2 | 119 | 2 | 16826525 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15899844 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 30103670 | ||
| Pubmed | Recent advances in functional conservation and divergence of recombinase RAD51 and DMC1. | 1.16e-05 | 2 | 119 | 2 | 35729697 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28751376 | ||
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 1.16e-05 | 2 | 119 | 2 | 35562743 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 14718558 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8602360 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26088134 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27052786 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33446654 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20833135 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22573551 | ||
| Pubmed | Congenital mirror movements: phenotypes associated with DCC and RAD51 mutations. | 1.16e-05 | 2 | 119 | 2 | 25813273 | |
| Pubmed | Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. | 1.16e-05 | 2 | 119 | 2 | 23523133 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9539976 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 1.16e-05 | 2 | 119 | 2 | 11672541 | |
| Pubmed | GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies. | 1.16e-05 | 2 | 119 | 2 | 38688280 | |
| Pubmed | EXOSC10 MYH10 NUP98 PRPF8 ST13 SF3B1 TLN1 RPF2 ASCC3 CNP NUP153 | 1.28e-05 | 638 | 119 | 11 | 33239621 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 SEC16B TCF20 NUP98 GPATCH8 MECP2 PCF11 LIG1 SF3B1 SHCBP1 NUP153 HOMEZ | 1.46e-05 | 774 | 119 | 12 | 15302935 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.51e-05 | 153 | 119 | 6 | 26365490 | |
| Pubmed | 1.70e-05 | 538 | 119 | 10 | 28524877 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 PHACTR2 SH3KBP1 PLEKHA6 FNBP1L GORASP2 SHANK2 AHNAK TLN1 EPB41L1 | 2.58e-05 | 565 | 119 | 10 | 25468996 |
| Pubmed | MAGI1 MYH10 TCF20 TBC1D5 SH3KBP1 SF3B1 SHANK2 SBF1 SLC4A4 CNP EPB41L1 NUP153 SMG6 | 2.71e-05 | 963 | 119 | 13 | 28671696 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.83e-05 | 349 | 119 | 8 | 25665578 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.00e-05 | 256 | 119 | 7 | 33397691 | |
| Pubmed | MYH10 REXO4 TCF20 NACA SH3KBP1 NUP98 SOX17 KLF15 TNIP1 GPATCH8 ZHX2 PCF11 LIG3 SALL1 KDM1B HOMEZ | 3.03e-05 | 1429 | 119 | 16 | 35140242 | |
| Pubmed | 3.07e-05 | 18 | 119 | 3 | 18664271 | ||
| Pubmed | EXOSC10 MYH10 NCF1 NACA LAMB1 PRPF8 ST13 LIG3 SF3B1 AHNAK TLN1 RPF2 OS9 ASCC3 CNP AHNAK2 | 3.32e-05 | 1440 | 119 | 16 | 30833792 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.39e-05 | 358 | 119 | 8 | 32460013 | |
| Pubmed | The meiosis-specific recombinase hDmc1 forms ring structures and interacts with hRad51. | 3.47e-05 | 3 | 119 | 2 | 10562567 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 11896201 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 14627836 | ||
| Pubmed | Nup50 is required for cell differentiation and exhibits transcription-dependent dynamics. | 3.47e-05 | 3 | 119 | 2 | 24943837 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21655080 | ||
| Pubmed | Biochemical analysis of the N-terminal domain of human RAD54B. | 3.47e-05 | 3 | 119 | 2 | 18718930 | |
| Pubmed | Tid1/Rdh54 promotes colocalization of rad51 and dmc1 during meiotic recombination. | 3.47e-05 | 3 | 119 | 2 | 11005857 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9971820 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21307306 | ||
| Pubmed | The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. | 3.47e-05 | 3 | 119 | 2 | 34582559 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 14764457 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 17996711 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 31630206 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9847314 | ||
| Pubmed | Human PSF concentrates DNA and stimulates duplex capture in DMC1-mediated homologous pairing. | 3.47e-05 | 3 | 119 | 2 | 22156371 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 32152280 | ||
| Pubmed | Homeostatic control of recombination is implemented progressively in mouse meiosis. | 3.47e-05 | 3 | 119 | 2 | 22388890 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19589734 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21940993 | ||
| Pubmed | Subcellular distribution of non-muscle myosin IIb is controlled by FILIP through Hsc70. | 3.47e-05 | 3 | 119 | 2 | 28234934 | |
| Pubmed | Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion. | 3.47e-05 | 3 | 119 | 2 | 20407419 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 25763452 | ||
| Pubmed | Interactions between human BRCA2 protein and the meiosis-specific recombinase DMC1. | 3.47e-05 | 3 | 119 | 2 | 17541404 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9363683 | ||
| Pubmed | Uncommon somatic mutations in metastatic NUT midline carcinoma. | 3.47e-05 | 3 | 119 | 2 | 28967088 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 10516026 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 30389599 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21903585 | ||
| Pubmed | Downregulation of CNPase in a MeCP2 deficient mouse model of Rett syndrome. | 3.47e-05 | 3 | 119 | 2 | 22334035 | |
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 3.47e-05 | 3 | 119 | 2 | 21327100 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 32502153 | ||
| Pubmed | Purified human BRCA2 stimulates RAD51-mediated recombination. | 3.47e-05 | 3 | 119 | 2 | 20729832 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 18440984 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 33087274 | ||
| Pubmed | 3.53e-05 | 360 | 119 | 8 | 33111431 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | EXOSC10 MYH10 REXO4 TCF20 GPATCH8 PRPF8 LAP3 RTF1 LIG1 SF3B1 AHNAK RPF2 NUP153 | 3.56e-05 | 989 | 119 | 13 | 36424410 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH10 NUP98 TNIP1 FNBP1L PRPF8 MECP2 MEN1 LIG3 SF3B1 SALL1 DLX1 KDM1B | 3.95e-05 | 857 | 119 | 12 | 25609649 |
| Pubmed | EXOSC10 TCF20 NUP98 GPATCH8 PRPF8 NT5DC1 RTF1 LIG3 GTF2E2 SF3B1 AHNAK KDM1B NUP153 | 4.60e-05 | 1014 | 119 | 13 | 32416067 | |
| Pubmed | STAM2 EXOSC10 LAMB1 TNIP1 PRPF8 ST13 PCF11 GTF2E2 SF3B1 SBF1 TLN1 RPF2 OS9 ASCC3 EPB41L1 MAST3 | 4.87e-05 | 1487 | 119 | 16 | 33957083 | |
| Pubmed | A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. | 4.97e-05 | 21 | 119 | 3 | 24025145 | |
| Interaction | LRRC59 interactions | PTGES2 SPAST ZFYVE27 RHBDF2 DOCK8 RNF113A NUP98 KLF15 LAMB1 TNIP1 PRPF8 MECP2 ELOVL2 TGOLN2 GORASP2 SF3B1 OS9 ASCC3 MAST3 | 2.60e-07 | 845 | 114 | 19 | int:LRRC59 |
| Interaction | NUP43 interactions | RAD51 REXO4 SPAST TCF20 NUP98 ZDHHC7 CCDC168 GPATCH8 ZHX2 MECP2 RTF1 TDRD7 LIG3 TRAPPC12 NUP153 AHNAK2 | 4.66e-07 | 625 | 114 | 16 | int:NUP43 |
| Interaction | NXF1 interactions | RAD51 MAGI1 EXOSC10 REXO4 SH3KBP1 NUP98 ZDHHC7 TNIP1 FNBP1L PRPF8 MECP2 PCF11 PPP1R26 LIG3 GTF2E2 AHNAK TLN1 SHCBP1 RPF2 ASCC3 SLC25A19 NUP153 HOMEZ | 1.54e-06 | 1345 | 114 | 23 | int:NXF1 |
| Interaction | DDX23 interactions | MYH10 REXO4 RNF113A TNIP1 GPATCH8 PRPF8 MECP2 MEN1 RTF1 LIG3 GTF2E2 SF3B1 | 1.78e-05 | 480 | 114 | 12 | int:DDX23 |
| Interaction | XRCC6 interactions | EXOSC10 MYH10 REXO4 TCF20 RNF113A TNIP1 PRPF8 MECP2 ST13 RTF1 PCF11 LIG3 GTF2E2 SF3B1 DENND5A NUP153 MAST3 | 1.80e-05 | 928 | 114 | 17 | int:XRCC6 |
| Interaction | U2AF2 interactions | RNF113A TNIP1 GPATCH8 PRPF8 MECP2 ST13 LAP3 MEN1 PCF11 LIG1 SF3B1 AHNAK TLN1 RPF2 | 1.87e-05 | 651 | 114 | 14 | int:U2AF2 |
| Interaction | NUP85 interactions | 2.99e-05 | 156 | 114 | 7 | int:NUP85 | |
| Interaction | SUMO2 interactions | RAD51 EXOSC10 NACA TNIP1 GPATCH8 PRPF8 SF3B1 SALL1 AHNAK TLN1 NUP153 HOMEZ AHNAK2 | 3.00e-05 | 591 | 114 | 13 | int:SUMO2 |
| Interaction | NAA40 interactions | STAM2 EXOSC10 MYH10 TBC1D5 RNF113A NACA NUP98 PRPF8 MECP2 LIG3 GTF2E2 GORASP2 SF3B1 AHNAK TLN1 NUP153 AHNAK2 | 3.50e-05 | 978 | 114 | 17 | int:NAA40 |
| Interaction | MTA2 interactions | MYH10 TCF20 RNF113A SH3KBP1 TNIP1 MECP2 TGOLN2 MEN1 GTF2E2 SALL1 AHNAK | 3.66e-05 | 435 | 114 | 11 | int:MTA2 |
| Interaction | SULF2 interactions | 5.92e-05 | 119 | 114 | 6 | int:SULF2 | |
| Interaction | ZNF284 interactions | 6.13e-05 | 14 | 114 | 3 | int:ZNF284 | |
| Interaction | SAMD1 interactions | 7.12e-05 | 123 | 114 | 6 | int:SAMD1 | |
| Interaction | PLOD2 interactions | 7.43e-05 | 180 | 114 | 7 | int:PLOD2 | |
| Interaction | CPSF1 interactions | 1.02e-04 | 255 | 114 | 8 | int:CPSF1 | |
| Interaction | NOP16 interactions | 1.08e-04 | 191 | 114 | 7 | int:NOP16 | |
| GeneFamily | PDZ domain containing | 3.99e-05 | 152 | 75 | 6 | 1220 | |
| GeneFamily | DNA ligases|Nucleotide excision repair | 5.08e-05 | 3 | 75 | 2 | 1247 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.50e-04 | 161 | 75 | 5 | 593 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.72e-03 | 15 | 75 | 2 | 529 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | KANSL1L LAMB1 PLEKHA6 GRHL2 SGMS1 SHANK2 UGT2B7 NRG3 EPB41L1 | 1.83e-09 | 197 | 112 | 9 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-08 | 194 | 112 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-08 | 194 | 112 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-08 | 194 | 112 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-08 | 195 | 112 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-08 | 196 | 112 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-08 | 196 | 112 | 8 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.47e-07 | 185 | 112 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.16e-07 | 189 | 112 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.54e-07 | 191 | 112 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.73e-07 | 192 | 112 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.73e-07 | 192 | 112 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.94e-07 | 193 | 112 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-07 | 194 | 112 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.36e-07 | 195 | 112 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.58e-07 | 196 | 112 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 199 | 112 | 7 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.29e-07 | 199 | 112 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.54e-07 | 200 | 112 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 7.54e-07 | 200 | 112 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.06e-06 | 173 | 112 | 6 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.58e-06 | 176 | 112 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.98e-06 | 183 | 112 | 6 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.98e-06 | 183 | 112 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.43e-06 | 185 | 112 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.66e-06 | 186 | 112 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.90e-06 | 187 | 112 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 187 | 112 | 6 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.39e-06 | 189 | 112 | 6 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.65e-06 | 190 | 112 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-06 | 191 | 112 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-06 | 191 | 112 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.91e-06 | 191 | 112 | 6 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.91e-06 | 191 | 112 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.91e-06 | 191 | 112 | 6 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.18e-06 | 192 | 112 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-06 | 192 | 112 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.46e-06 | 193 | 112 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.46e-06 | 193 | 112 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.46e-06 | 193 | 112 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 193 | 112 | 6 | e7012f7b53971972299db34fa51ff51a4e4987fe | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-06 | 193 | 112 | 6 | b1893193766ae41bf2ab6ed4083285c9c814e608 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-06 | 193 | 112 | 6 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.74e-06 | 194 | 112 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.74e-06 | 194 | 112 | 6 | 4e93bd903cddfd0c8f220b6a35b449895de4119b | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 9.74e-06 | 194 | 112 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-06 | 194 | 112 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-06 | 194 | 112 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-06 | 194 | 112 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-05 | 195 | 112 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 196 | 112 | 6 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 196 | 112 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-05 | 197 | 112 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 197 | 112 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 197 | 112 | 6 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-05 | 198 | 112 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.13e-05 | 199 | 112 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.13e-05 | 199 | 112 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.16e-05 | 200 | 112 | 6 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.16e-05 | 200 | 112 | 6 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 112 | 6 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.76e-05 | 149 | 112 | 5 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-05 | 150 | 112 | 5 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-05 | 156 | 112 | 5 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-05 | 158 | 112 | 5 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-05 | 158 | 112 | 5 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.65e-05 | 168 | 112 | 5 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 6.65e-05 | 168 | 112 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.65e-05 | 168 | 112 | 5 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.65e-05 | 168 | 112 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 170 | 112 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 7.43e-05 | 172 | 112 | 5 | c3822ff7329c3ac38c68c5c38cd67c390682e2a6 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 7.43e-05 | 172 | 112 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.28e-05 | 176 | 112 | 5 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.28e-05 | 176 | 112 | 5 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.28e-05 | 176 | 112 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.28e-05 | 176 | 112 | 5 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.50e-05 | 177 | 112 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.50e-05 | 177 | 112 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.50e-05 | 177 | 112 | 5 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| Disease | Glaucoma | 4.40e-06 | 9 | 112 | 3 | C0017601 | |
| Disease | chemotherapy-induced alopecia | 4.27e-05 | 3 | 112 | 2 | EFO_0005400 | |
| Disease | renal tubular acidosis (is_implicated_in) | 8.53e-05 | 4 | 112 | 2 | DOID:14219 (is_implicated_in) | |
| Disease | retinoblastoma (is_marker_for) | 8.53e-05 | 4 | 112 | 2 | DOID:768 (is_marker_for) | |
| Disease | congenital mirror movement disorder (is_implicated_in) | 8.53e-05 | 4 | 112 | 2 | DOID:0111153 (is_implicated_in) | |
| Disease | Distal Renal Tubular Acidosis | 1.42e-04 | 5 | 112 | 2 | C1704380 | |
| Disease | Child Development Disorders, Specific | 1.81e-04 | 29 | 112 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.81e-04 | 29 | 112 | 3 | C0085996 | |
| Disease | Profound Mental Retardation | 1.93e-04 | 139 | 112 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.93e-04 | 139 | 112 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.93e-04 | 139 | 112 | 5 | C0917816 | |
| Disease | Developmental Disabilities | 2.01e-04 | 30 | 112 | 3 | C0008073 | |
| Disease | Trichothiodystrophy Syndromes | 2.12e-04 | 6 | 112 | 2 | C1955934 | |
| Disease | Autism spectrum disorder | 2.96e-04 | 7 | 112 | 2 | cv:C1510586 | |
| Disease | Intellectual Disability | 3.14e-04 | 447 | 112 | 8 | C3714756 | |
| Disease | hip circumference | 3.15e-04 | 338 | 112 | 7 | EFO_0005093 | |
| Disease | JT interval | 3.78e-04 | 248 | 112 | 6 | EFO_0007885 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 3.94e-04 | 8 | 112 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | SEC16B REXO4 KLF15 TNIP1 FNBP1L ECI1 NT5DC1 CTCFL GORASP2 AHNAK UGT2B7 HOMEZ | 4.84e-04 | 1015 | 112 | 12 | EFO_0004533 |
| Disease | autistic disorder (is_implicated_in) | 5.49e-04 | 42 | 112 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | vitamin D measurement, COVID-19 | 8.64e-04 | 49 | 112 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 9.19e-04 | 12 | 112 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Sjogren's Syndrome | 1.08e-03 | 13 | 112 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 1.08e-03 | 13 | 112 | 2 | C0086981 | |
| Disease | information processing speed, response to cranial radiation therapy | 1.41e-03 | 58 | 112 | 3 | EFO_0004363, EFO_0010950 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.45e-03 | 15 | 112 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Yu-Zhi constitution type | 1.45e-03 | 15 | 112 | 2 | EFO_0007638 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 1.45e-03 | 15 | 112 | 2 | DOID:655 (is_implicated_in) | |
| Disease | irritable bowel syndrome | 1.59e-03 | 131 | 112 | 4 | EFO_0000555 | |
| Disease | Cannabis use | 1.65e-03 | 16 | 112 | 2 | EFO_0007585 | |
| Disease | age at initiation of smoking | 2.05e-03 | 66 | 112 | 3 | EFO_0021784 | |
| Disease | Tourette syndrome, schizophrenia | 2.10e-03 | 18 | 112 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | C-reactive protein measurement | SEC16B NCF1 KLF15 TNIP1 CCDC168 FNBP1L NT5DC1 ST13 DMC1 SALL1 AHNAK PCDH15 | 2.12e-03 | 1206 | 112 | 12 | EFO_0004458 |
| Disease | Lupus Erythematosus, Systemic | 2.52e-03 | 71 | 112 | 3 | C0024141 | |
| Disease | respiratory symptom measurement, COVID-19 | 2.84e-03 | 74 | 112 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | hemoglobin change measurement | 3.14e-03 | 22 | 112 | 2 | EFO_0600027 | |
| Disease | osteoarthritis, knee | 3.14e-03 | 158 | 112 | 4 | EFO_0004616 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 3.50e-03 | 801 | 112 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Pseudoaphakia | 3.73e-03 | 24 | 112 | 2 | C0524524 | |
| Disease | Lens Opacities | 3.73e-03 | 24 | 112 | 2 | C1510497 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEPKTLGKAMGDFTP | 76 | Q6PI77 | |
| GKYVSVAPVPDTMGK | 1151 | Q86US8 | |
| STTKGEQFPGEMFPV | 621 | Q8NI51 | |
| FSMPSLKGEGPEFDV | 1006 | Q09666 | |
| SMPGFKGEGPEVDVK | 1391 | Q09666 | |
| FSMPGFKAEGPEVDV | 2056 | Q09666 | |
| PKFSMPGFKAEGPEV | 2516 | Q09666 | |
| KFSMPGFKAEGPEVD | 2901 | Q09666 | |
| KFSMPGFKGEGPDVD | 3811 | Q09666 | |
| GAAPDISVKGPAFNM | 5536 | Q09666 | |
| NSPVSGKAVFMEFGP | 11 | P56177 | |
| ATMTFQADPKKPIGG | 276 | Q14565 | |
| MGNTSVGPEVKFKGV | 266 | Q06278 | |
| ESMGGKVPPATQKAK | 36 | Q8NFI4 | |
| ESMGGKVPPATQKAK | 36 | P50502 | |
| AAMFAADPKKPIGGN | 276 | Q06609 | |
| PEGPVLTFQSEKMKG | 551 | O00255 | |
| ENMPSGKANKPGDVV | 336 | P28838 | |
| KGMGQDPFFLSKPSS | 106 | P56975 | |
| EMKNIEKPSGTDPAG | 1161 | P43146 | |
| KSGKGAAAMIPGPQT | 761 | Q9H4G0 | |
| DDEPSLANGAFMPKK | 581 | P52948 | |
| KGDTFSQMLGFPTPE | 41 | A0AUZ9 | |
| VGNAKPAETLKPMGN | 1026 | Q15746 | |
| TGKPEPKVVYFGDSM | 301 | Q5TFE4 | |
| KVNGMKDARPSSPAD | 601 | Q96QZ7 | |
| PFEEGKKISLPGQMA | 206 | Q9H8Y8 | |
| GMIQKDQTDKPPTGN | 51 | Q0VAK6 | |
| GGAENTAPKPSFVAM | 311 | Q5SZK8 | |
| KSKPVAVTGMAFPTG | 436 | O14576 | |
| GSGPMFKPTTVAVDE | 211 | Q9UKJ3 | |
| EFTEMCPKGKGFVPA | 1396 | Q14766 | |
| KNEDQKPGGVIPMAF | 1851 | Q02817 | |
| MPKDGKSTATDITGP | 141 | P14598 | |
| MGVPEKIKTDNGPGY | 701 | P63132 | |
| EASFPGISTGPMKKV | 171 | P07942 | |
| ATMTDQGPSKEKVPG | 156 | P59047 | |
| GAEEQNTGKFKSMVP | 311 | O75167 | |
| KVVPNPFSESGGDMK | 121 | P49916 | |
| KSTRSAKPVGPEDMG | 101 | O15541 | |
| MGVPEKIKTDNGPGY | 701 | P63135 | |
| MGVPEKIKTDNGPGY | 701 | Q9BXR3 | |
| AAAKMQGAPPAVKAE | 521 | O95248 | |
| PTMGAPKTVDEKAFF | 1821 | O95248 | |
| ARDGPTKMIFEGPNK | 761 | O94913 | |
| MGVPEKIKTDNGPGY | 701 | Q9QC07 | |
| YKGMVAPDAVKGTPI | 931 | Q96QU1 | |
| PDAGAGVAVMKFKNP | 51 | P42126 | |
| SATKSDGEMVLPGFP | 16 | Q01780 | |
| NRDPEPGGATEKMKT | 651 | Q711Q0 | |
| EFGPVPSKQMKEEGT | 521 | Q6ISB3 | |
| GKTEPSPKAFMADQQ | 121 | Q8NB78 | |
| NAMPVIFGKSSGPEF | 596 | Q8NF50 | |
| MVVDSFKSGFEPPGD | 266 | Q5T0N5 | |
| MQEPPAGKEVKNGFS | 266 | Q9NXB9 | |
| MKTKFCTGGEAEPSP | 1 | P35790 | |
| KPQISGFSSPVMEGD | 126 | Q8N3J6 | |
| MSSSGAKDKPELQFP | 21 | P09543 | |
| VPSKKLGGSMFTANP | 961 | Q6IQ26 | |
| PKGIVFSMPVKFENG | 411 | Q5I0G3 | |
| TSGRNKNDDMVPPGK | 146 | Q6MZM0 | |
| DSGKQFQVPMTKPGE | 846 | Q6MZM0 | |
| MPKFAFSSEDEGVGP | 786 | O60307 | |
| TTATFFKMPQEKSPG | 466 | Q9NWQ4 | |
| NMEPGVKEVPEGNSK | 151 | Q9UIH9 | |
| KPGTGSFSKDAQGPM | 441 | Q86VF2 | |
| SEGHKSEGTMPPNKE | 16 | Q8IX15 | |
| FPKGMKSSDGVQVFD | 3491 | Q8NDH2 | |
| VGANPFGKMLPVDEF | 511 | Q8IYK4 | |
| FPPAMVDAGKGKTAE | 476 | P18858 | |
| FPNVDGVVMGKPFKD | 246 | Q8N7B9 | |
| LGGNPVKFPEMFQKD | 1206 | Q9NSC2 | |
| VFSVAPVKGVMDPGK | 1421 | Q9C0B2 | |
| PVKGVMDPGKTQDFT | 1426 | Q9C0B2 | |
| LTPNAIPKGFMDGKQ | 731 | P35580 | |
| MYGSPPSKNEAGKQK | 296 | Q8NGC1 | |
| LVKMPFQTSPGGKAE | 221 | P51608 | |
| SPQVKGEEMPAGKDQ | 111 | Q9GZR2 | |
| SGVLPDAPKEMSKGQ | 626 | Q92541 | |
| GISSMQESGPKKVAP | 241 | P29084 | |
| GLKESETGFMFSDPP | 701 | Q8IW52 | |
| ETGFMFSDPPGQKVV | 706 | Q8IW52 | |
| FNGSGKPIDKGPVVM | 126 | P15313 | |
| DMKVKGEAPANSGAP | 41 | Q9H6I2 | |
| GAGRKKSMDQPEGTP | 211 | Q8N3T6 | |
| MPQKQKSGDTTLGPE | 961 | Q7Z7B0 | |
| PTGGIFNPAKELMAK | 296 | Q8IZP6 | |
| EDKVMEGKGQSPFDP | 166 | Q9H3S1 | |
| NSPSLFGTEGKPKME | 586 | Q96B97 | |
| FGTEGKPKMEPAASS | 591 | Q96B97 | |
| AAVGKDRPFMGGQKP | 316 | Q9H7Z7 | |
| GKKPPSVFGSTAERM | 766 | Q5T8A7 | |
| KPGSSLQSFMPEGKT | 51 | Q8NEM2 | |
| FGPPGNGKTMLAKAV | 381 | Q9UBP0 | |
| KGNSVGVKPDAEMSP | 146 | Q8NHU6 | |
| VAPQKMAGASPTKDD | 291 | Q13438 | |
| PEGTKPMLIFAGDDF | 136 | Q9H7B2 | |
| QQMPSKPEGAAKTIG | 451 | Q9UPX8 | |
| AMKESQQGPKGEAPK | 1226 | Q9UPX8 | |
| GEKGRSTKPGFAMPK | 5011 | Q8IVF2 | |
| GSMGKPSPAFDVKIV | 396 | Q53FZ2 | |
| ETKAIKQMFGPFPSS | 111 | Q8N3C0 | |
| TDLPPKGKNNMGEAF | 56 | Q9H7R5 | |
| SKALNMAIPGGPKFE | 266 | Q6P2Q9 | |
| NKEGASGRPGSPKME | 256 | Q15025 | |
| GSPPKEEKEKMSGSA | 336 | O43493 | |
| PKSAVFPGEGKVKMS | 806 | Q9Y2H5 | |
| GNSGGKIQPEMKTFP | 76 | Q9UK11 | |
| FGVDEKSPPAMKTDV | 126 | Q9UBY0 | |
| SGDGFEPQMVKSPSF | 171 | Q8WVT3 | |
| EPQMVKSPSFGGASE | 176 | Q8WVT3 | |
| FADGGKTPDPKMNAR | 136 | O75533 | |
| PGGKMVAAAKASVPT | 996 | Q9Y490 | |
| MGVPEKIKTDNGPGY | 701 | P10266 | |
| MGVPEKIKTDNGPGY | 701 | P63133 | |
| MGVPEKIKTDNGPGY | 701 | Q9UQG0 | |
| GSFSIKIKPNGMPNG | 96 | Q86VZ5 | |
| MKEEGITFPPAGSQT | 136 | O75886 | |
| GSINPMSEGFKFSKP | 941 | P49790 | |
| AKDMPLSSDGNPKVN | 586 | Q9UGU0 | |
| QADVSSAGPKAPMKF | 261 | Q96JE7 | |
| KATKPMAESPKNGGD | 711 | Q9Y6X8 | |
| KVPKSSMGATAPEAQ | 381 | Q5T4F4 | |
| MKAGSRTGKPQEPVT | 151 | Q9UL58 | |
| MLTDPGAVPKGNATK | 101 | Q9NXF8 | |
| KMETETSAPGEQPKF | 856 | Q9Y6R1 | |
| DGQKGKETLMTPIPF | 271 | Q92609 | |
| KPLPKEMEDFVQSSG | 286 | P16662 | |
| FTKTQMKPGVVPGCE | 1326 | O75093 | |
| GPPMDKSDLGQKRTS | 531 | Q6PJF5 | |
| MVGYDPKPDGRNNTK | 1 | Q9HC21 | |
| QEKPMEIAPSAGFGG | 721 | O75385 | |
| PKSEQFKMPEGGEGK | 91 | Q8WWM1 | |
| TMGEFKEESSPVGFP | 1361 | Q9NR99 | |
| MGATVPQASKGLPAK | 1661 | E9PAV3 |